DI FEBO, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 2.923
EU - Europa 2.226
AS - Asia 2.011
AF - Africa 200
SA - Sud America 117
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 7.480
Nazione #
US - Stati Uniti d'America 2.898
SG - Singapore 598
GB - Regno Unito 579
CN - Cina 578
VN - Vietnam 367
SE - Svezia 358
DE - Germania 351
UA - Ucraina 204
HK - Hong Kong 189
IT - Italia 170
IN - India 129
RU - Federazione Russa 113
IE - Irlanda 97
BR - Brasile 93
FR - Francia 92
CH - Svizzera 74
TG - Togo 64
NL - Olanda 61
JP - Giappone 46
ZA - Sudafrica 40
CI - Costa d'Avorio 39
SC - Seychelles 33
FI - Finlandia 30
JO - Giordania 30
KR - Corea 30
BG - Bulgaria 24
EE - Estonia 23
CA - Canada 16
BE - Belgio 15
IR - Iran 14
NG - Nigeria 13
RO - Romania 9
AR - Argentina 8
GR - Grecia 8
ID - Indonesia 8
CL - Cile 7
BD - Bangladesh 6
MX - Messico 5
EG - Egitto 4
ES - Italia 4
AT - Austria 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
PL - Polonia 3
PY - Paraguay 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LB - Libano 2
PE - Perù 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BH - Bahrain 1
BW - Botswana 1
CD - Congo 1
CO - Colombia 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IQ - Iraq 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
TT - Trinidad e Tobago 1
Totale 7.480
Città #
Southend 494
Singapore 427
Chandler 335
Ashburn 305
Fairfield 243
Hong Kong 188
Santa Clara 155
Jacksonville 145
Ann Arbor 139
Wilmington 138
Houston 113
Princeton 111
Seattle 110
Hefei 108
Woodbridge 106
Cambridge 99
Dublin 97
Beijing 91
Dong Ket 79
Boardman 77
Bern 73
Lomé 64
Ho Chi Minh City 59
Nanjing 49
Tokyo 45
Hanoi 41
Padova 41
Westminster 41
Berlin 40
Abidjan 39
Los Angeles 32
Amman 30
Turin 29
Seoul 26
Mülheim 25
Sofia 24
Buffalo 23
Jinan 23
Munich 23
Helsinki 22
Saint Petersburg 21
San Diego 21
New York 17
Redondo Beach 17
Mahé 16
Shanghai 16
Bologna 15
Dallas 15
Falkenstein 15
Frankfurt am Main 15
Brussels 14
Nanchang 14
Shenyang 14
Abeokuta 13
Bengaluru 13
Des Moines 13
Haiphong 13
Medford 13
Milan 13
Verona 13
Changsha 10
Guangzhou 10
Tianjin 10
Washington 10
London 9
São Paulo 8
Turku 8
Zhengzhou 8
Bremen 7
Da Nang 7
Hebei 7
Thái Nguyên 7
Biên Hòa 6
Brooklyn 6
Dearborn 6
Kunming 6
Leawood 6
Ningbo 6
Redwood City 6
Taiyuan 6
Toronto 6
Yubileyny 6
Bühl 5
Chicago 5
Hangzhou 5
Jiaxing 5
Norwalk 5
Olalla 5
Phoenix 5
Quận Một 5
Redmond 5
Taizhou 5
Amsterdam 4
Atlanta 4
Cairo 4
Can Tho 4
Düsseldorf 4
Haikou 4
Lanzhou 4
Lauterbourg 4
Totale 4.853
Nome #
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 235
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 222
Erosions or not in GORD? The potential role of oesophageal cell proliferation 216
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 194
Implications of antioxidant protein in human gastric neoplasm 189
Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? 186
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 184
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 182
Activity and expression of superoxide dismutase in human gastric neoplasm. 182
Differential activity and expression of superoxide dismutase in human gastric neoplasm 178
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 177
Endoscopic appearance of GERD: Putative role of cell proliferation 175
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 174
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. 171
Ex vivo HR-MAS Magnetic Resonance Spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa 167
Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. 167
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 161
Implications of antioxidant enzymes in human gastric neoplasms 160
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 156
Mesalazine with or without cholestyramine in the treatment of microscopic colitis: Randomized controlled trial 154
Cytochrome P450 (CYP1A/1A2)and SODs expression in human gastric neoplasm 152
THE ROLE OF SOD, CAT AND CYP1A1/1A2 IN HUMAN GASTRIC NEOPLASM   149
Role of Biologics in refractory pouchitis 149
Capsule endoscopy revealing small-intestinal lymphangiectasia and GI stromal tumor polyps in neurofibromatosis type 1. 149
Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa 148
Long-term management of GERD in the elderly with pantoprazole 148
Erosions or not in GERD? The potential role of esophageal cell kinetics 147
Molecular characterization of human gastric mucosa by HR-MAS magnetic resonance spectroscopy 143
Pre-pouch ileitis 142
Cytochrome P450 (CYP 1A1/1A2) expression and lipid profile in human gastric neoplasm 137
Discrimination of Healthy and Neoplastic Human Colon Tissues by ex Vivo HR-MAS NMR Spectroscopy and Chemometric Analyses 136
Cytochrome P450 (CYP 1A1/1A2) and SODs expression in human gastric neoplasm 135
Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. 134
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 134
Colitis evolving into ulcerative colitis 119
The role of SOD, CAT and CYP1A1/1A2 in human gastric neoplasm. 116
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 112
Dilated intercellular spaces as a marker of oesophageal damage: Comparative results in gastro-oesophageal reflux disease with or without bile reflux 112
Cancer surveillance in ulcerative colitis: Critical analysis of long-term prospective programme 109
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis 108
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 105
Correlation between endoscopic features of gastric antrum, histology and Helicobacter pylori infection in adults 104
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 98
OXIDATIVE RESPONSES IN DIFFERENT HUMAN GASTRIC NEOPLASMS 98
Pantoprazole, azithromycin and tinidazole: Short duration triple therapy for eradication of Helicobacter pylori infection 92
Risk of duodenal cancer in patients with familial adenomatous polyposis 88
Lack of association with spondyloarthritis and HLA-B27 in Italian patients with Whipple's disease 85
Cost-effectiveness analysis of the preparation of colonoscopy. Comparison between a PEG-electrolyte solution and a standard preparation 84
Squamous cell carcinoma arising in esophageal lichen planus 82
Severe and relapsing upper gastrointestinal bleeding in a patient with Glanzmann's thrombasthenia 80
Diffuse esophageal leiomyomatosis: Case report and review 69
Oesophageal tuberculosis mimicking secondary oesophageal involvement of mediastinal neoplasm 58
New trends in non-absorbable antibiotics in gastrointestinal disease 56
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 49
Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis 38
Familial adenomatous polyposis and inflammatory bowel disease associated in two kindreds 36
Diffuse oesophageal leiomyomatosis 31
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 17
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 16
Totale 7.595
Categoria #
all - tutte 21.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021479 0 0 0 0 0 40 21 41 72 48 35 222
2021/20221.108 64 40 84 101 100 69 18 65 45 89 264 169
2022/20231.367 126 230 70 145 104 105 36 64 246 18 94 129
2023/2024290 21 57 28 26 27 69 14 10 3 12 10 13
2024/20251.146 58 146 79 87 262 65 64 19 7 79 18 262
2025/20261.288 197 294 242 205 335 15 0 0 0 0 0 0
Totale 7.595